FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080483642> ?p ?o ?g. }

• W3080483642 endingPage "327" @default.
• W3080483642 startingPage "324" @default.
• W3080483642 abstract "Many people with type 2 diabetes are treated with insulin with the goal of achieving a specific A1C target. The most prominent risk for people on insulin therapy is hypoglycemia. When basal insulin analogs are used appropriately, the risk of hypoglycemia can be reduced while still achieving individualized glycemic goals.In a series of short videos now available on the Clinical Diabetes website, the authors discuss approaches to optimizing basal insulin initiation and treatment in people with type 2 diabetes, including those at high risk such as individuals with renal impairment and older adults, with a focus on reaching A1C goals while mitigating the risk for hypoglycemia.This article is intended to briefly summarize those discussions, and readers are encouraged to view the videos in their entirety at https://clinical.diabetesjournals.org/content/basal-insulin-videos.### Introduction (Available at https://bcove.video/2Q2Rb9b)Approximately 50% of people with type 2 diabetes have poorly controlled disease and are vulnerable to long-term micro- and macrovascular complications (1). As type 2 diabetes progresses, many patients will require insulin to maintain glycemic control. The appropriate use of insulin requires a balance between the need for tight glucose control and the potential risk for hypoglycemia. Definitions of hypoglycemia have evolved over time, and the American Diabetes Association (ADA) now uses a three-level classification of hypoglycemia severity (2). Mitigating the risk for hypoglycemia is crucial to the successful treatment of people with type 2 diabetes. In the following series of videos, the authors discuss the use of available insulin formulations in the context of hypoglycemia risk.### Basal Insulin Therapy—Balancing Glycemic Control With Risk for Hypoglycemia (Available at https://bcove.video/3h3Y85h)The achievement of tight glycemic control reduces micro- and macrovascular complications, and adherence to treatment improves quality of life and decreases health care costs (3–9). The authors discuss the association between A1C reduction and microvascular complications, as reported in the UK …" @default.
• W3080483642 created "2020-09-01" @default.
• W3080483642 creator A5031453333 @default.
• W3080483642 creator A5032877471 @default.
• W3080483642 creator A5044466000 @default.
• W3080483642 creator A5066279531 @default.
• W3080483642 date "2020-08-21" @default.
• W3080483642 modified "2023-10-14" @default.
• W3080483642 title "Effective Initiation and Treatment With Basal Insulin in People With Type 2 Diabetes: Focus on Mitigating Hypoglycemia in Patients at Increased Risk: Executive Summary" @default.
• W3080483642 cites W1842840699 @default.
• W3080483642 cites W1849264946 @default.
• W3080483642 cites W2004643446 @default.
• W3080483642 cites W2096442161 @default.
• W3080483642 cites W2109416725 @default.
• W3080483642 cites W2123946565 @default.
• W3080483642 cites W2147999853 @default.
• W3080483642 cites W2171294019 @default.
• W3080483642 cites W2418958746 @default.
• W3080483642 cites W2493860075 @default.
• W3080483642 cites W2531020345 @default.
• W3080483642 cites W2603131458 @default.
• W3080483642 cites W2625031949 @default.
• W3080483642 cites W2739009446 @default.
• W3080483642 cites W2742058503 @default.
• W3080483642 cites W2745310286 @default.
• W3080483642 cites W2758044071 @default.
• W3080483642 cites W2770468706 @default.
• W3080483642 cites W2777315381 @default.
• W3080483642 cites W2779186994 @default.
• W3080483642 cites W2793732091 @default.
• W3080483642 cites W2798206180 @default.
• W3080483642 cites W2807748168 @default.
• W3080483642 cites W2809031508 @default.
• W3080483642 cites W2883282832 @default.
• W3080483642 cites W2887818979 @default.
• W3080483642 cites W2893902716 @default.
• W3080483642 cites W2896025524 @default.
• W3080483642 cites W2903668473 @default.
• W3080483642 cites W2912438009 @default.
• W3080483642 cites W2933517521 @default.
• W3080483642 cites W2947726625 @default.
• W3080483642 cites W3014351387 @default.
• W3080483642 cites W51678914 @default.
• W3080483642 doi "https://doi.org/10.2337/cd20-0035" @default.
• W3080483642 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7566923" @default.
• W3080483642 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33132501" @default.
• W3080483642 hasPublicationYear "2020" @default.
• W3080483642 type Work @default.
• W3080483642 sameAs 3080483642 @default.
• W3080483642 citedByCount "0" @default.
• W3080483642 crossrefType "journal-article" @default.
• W3080483642 hasAuthorship W3080483642A5031453333 @default.
• W3080483642 hasAuthorship W3080483642A5032877471 @default.
• W3080483642 hasAuthorship W3080483642A5044466000 @default.
• W3080483642 hasAuthorship W3080483642A5066279531 @default.
• W3080483642 hasBestOaLocation W30804836421 @default.
• W3080483642 hasConcept C126322002 @default.
• W3080483642 hasConcept C134018914 @default.
• W3080483642 hasConcept C177713679 @default.
• W3080483642 hasConcept C2777180221 @default.
• W3080483642 hasConcept C2778024521 @default.
• W3080483642 hasConcept C2779306644 @default.
• W3080483642 hasConcept C2780473172 @default.
• W3080483642 hasConcept C2780668416 @default.
• W3080483642 hasConcept C2781232474 @default.
• W3080483642 hasConcept C2909524832 @default.
• W3080483642 hasConcept C555293320 @default.
• W3080483642 hasConcept C71924100 @default.
• W3080483642 hasConceptScore W3080483642C126322002 @default.
• W3080483642 hasConceptScore W3080483642C134018914 @default.
• W3080483642 hasConceptScore W3080483642C177713679 @default.
• W3080483642 hasConceptScore W3080483642C2777180221 @default.
• W3080483642 hasConceptScore W3080483642C2778024521 @default.
• W3080483642 hasConceptScore W3080483642C2779306644 @default.
• W3080483642 hasConceptScore W3080483642C2780473172 @default.
• W3080483642 hasConceptScore W3080483642C2780668416 @default.
• W3080483642 hasConceptScore W3080483642C2781232474 @default.
• W3080483642 hasConceptScore W3080483642C2909524832 @default.
• W3080483642 hasConceptScore W3080483642C555293320 @default.
• W3080483642 hasConceptScore W3080483642C71924100 @default.
• W3080483642 hasIssue "4" @default.
• W3080483642 hasLocation W30804836421 @default.
• W3080483642 hasLocation W30804836422 @default.
• W3080483642 hasLocation W30804836423 @default.
• W3080483642 hasOpenAccess W3080483642 @default.
• W3080483642 hasPrimaryLocation W30804836421 @default.
• W3080483642 hasRelatedWork W12039364 @default.
• W3080483642 hasRelatedWork W12878900 @default.
• W3080483642 hasRelatedWork W14748982 @default.
• W3080483642 hasRelatedWork W15094999 @default.
• W3080483642 hasRelatedWork W15769231 @default.
• W3080483642 hasRelatedWork W1739382 @default.
• W3080483642 hasRelatedWork W19246136 @default.
• W3080483642 hasRelatedWork W20182274 @default.
• W3080483642 hasRelatedWork W7483762 @default.
• W3080483642 hasRelatedWork W1838118 @default.
• W3080483642 hasVolume "38" @default.
• W3080483642 isParatext "false" @default.

• next